Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

NCT01365481 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Chronic Kidney Disease

Interventions

DRUG: Valsartan
DRUG: amlodipine
DRUG: Hydrochlorothiazide

Sponsor

Novartis Pharmaceuticals